For laboratory research use only. Not for human consumption.
Free U.S. shipping on $200+GLPZone / The research collection
Illustrative certificateNS-2026-06029Nordicstar Analytical Sciences
AOD-9604 5 MG
Illustrative certificateNS-2026-06030Nordicstar Analytical Sciences
AOD-9604 10 MG
Metabolic Research
Growth hormone fragment identity & lipid research
A pair saves 10%. A set of three saves 15%.
For laboratory research use only.
Not for human consumption or clinical use.
The records shown here are illustrative. Request laboratory-issued documentation for your lot before ordering.
Priority, tracked shipping within the United States, free on orders of $200 or more after savings. Add Priority dispatch at checkout to have your order packed first; Private Clients receive it on every order. Follow the product documentation for laboratory handling requirements.
Shipping information01 / The compound
Growth hormone fragment identity & lipid research
AOD-9604 is a synthetic 16-amino-acid peptide derived from the C-terminal region of human growth hormone (hGH). Peer-reviewed analytical literature describes AOD9604 as hGH residues 177–191 with an additional tyrosine at the N-terminus.
AOD-9604 was developed to investigate biological activity associated with the C-terminal region of hGH without reproducing the complete structure of full-length growth hormone. Research has primarily examined lipid metabolism, lipolytic signaling, energy metabolism and related metabolic pathways.
AOD-9604, AOD 9604 and AOD9604 refer to the same research compound.
Sequence: YLRIVQCRSVEGSCGF
02 / Research profile
“HGH Fragment 176-191” is frequently used online when discussing peptides from the C-terminal region of human growth hormone, but it should not be treated as a chemically precise replacement name for AOD-9604.
Peer-reviewed analytical literature specifically defines AOD9604 as hGH residues 177–191 with an additional N-terminal tyrosine, producing the 16-residue sequence YLRIVQCRSVEGSCGF.
Preclinical studies have examined AOD-9604 in rodent models of lipid metabolism, including adipose-tissue lipolytic activity, energy expenditure and related metabolic endpoints. These findings are limited to the experimental models and conditions used in those studies.
Mouse studies have examined AOD-9604 in relation to β3-adrenergic signaling. Chronic exposure was associated with changes in β3-adrenergic receptor expression and lipolytic sensitivity, while knockout experiments indicated that the observed effects were not explained by direct β3-receptor activation alone.
Analytical research has characterized AOD-9604 as a 16-residue peptide corresponding to hGH residues 177–191 with an additional N-terminal tyrosine. In vitro incubation studies in serum and urine have also examined AOD-9604 metabolism and identified peptide-derived metabolites. These findings relate to compound characterization and analytical research rather than the characteristics of GLPZone material.
Reading the evidence
The cited findings describe the compound in the experimental systems used. Cellular, biochemical and animal results should be interpreted according to their model, methods and endpoints; they do not establish the performance of a GLPZone lot.
03 / Reference data
Reference specifications describe a compound. The final lot documentation identifies the material supplied.
| Compound | AOD-9604 |
|---|---|
| Research area | Metabolic Research |
| CAS number | 221231-10-3 |
| Molecular formula | C78H123N23O23S2 |
| Molecular weight | 1815.08 g/mol |
| Physical form | Lyophilized |
| Vial options | 5 MG · 10 MG |
| Intended use | Laboratory research only |
Variant amounts are nominal catalog quantities. They are not instructions for use.
HPLC separates components under a defined method. Read the reported percentage alongside the chromatogram, wavelength, integration method, and scope of the test.
Mass spectrometry provides molecular-mass evidence. Identity and chromatographic purity answer different questions; one cannot stand in for the other.
Connect the product name, variant, lot identifier, report date, and issuing laboratory. A report is useful only when its sample can be linked to the material being reviewed.
Every AOD-9604 lot is analyzed by Nordicstar Analytical Sciences for identity, content, and purity by HPLC with LC-MS confirmation. Each certificate carries a report number and verification key that can be checked at nordicstarlabs.com/verify. Research references below describe published science, not a certificate for a vial.
Read a COA with confidence| Presentation | Lot | HPLC purity | Tested | Certificate |
|---|---|---|---|---|
| 5 MG Current lot | GLZ-26-AOD-1028 | 99.712% | 19 Sep 2026 | NS-2026-06029 |
| 10 MG Current lot | GLZ-26-AOD-1029 | 99.569% | 17 Sep 2026 | NS-2026-06030 |
| 10 MG | GLZ-26-AOD-771 | 99.683% | 21 Aug 2026 | NS-2026-06131 |
| 5 MG | GLZ-26-AOD-772 | 99.762% | 20 Aug 2026 | NS-2026-06129 |
| 10 MG | GLZ-26-AOD-671 | 99.645% | 16 Jul 2026 | NS-2026-06132 |
| 5 MG | GLZ-26-AOD-672 | 99.721% | 06 Jul 2026 | NS-2026-06130 |
05 / Storage & handling
Keep unopened lyophilized AOD-9604 sealed and protected from heat, light and moisture.
Follow any product- or lot-specific documentation supplied with the material.
Explore the handling guide06 / Common questions
AOD-9604 is a synthetic 16-amino-acid peptide derived from the C-terminal region of human growth hormone. Published analytical research describes it as hGH residues 177–191 with an additional N-terminal tyrosine.
The published AOD-9604 sequence is YLRIVQCRSVEGSCGF. PubChem records the compound as a 16-residue peptide containing an intramolecular disulfide linkage.
The terms are often associated online, but they should not be treated as automatically interchangeable chemical names. Peer-reviewed literature defines AOD9604 specifically as hGH residues 177–191 with an additional N-terminal tyrosine.
Published research has investigated AOD-9604 in relation to lipid metabolism, lipolytic activity, energy metabolism, β3-adrenergic signaling and metabolic parameters. Much of the mechanistic evidence comes from animal or preclinical models.
AOD-9604 is a short synthetic peptide derived from the C-terminal region of human growth hormone rather than the complete hGH molecule. It is a distinct research compound with its own peptide sequence and analytical identity and should not be treated as another name for full-length human growth hormone.
07 / Further reading
Selected literature for context. Read each study’s methods, experimental model, and limitations alongside its findings.
Curated pairings
